About the bill
H.R. 1660 directs the Administrator of the United States Agency for International Development (USAID) to submit to Congress a report—with four annual updates—on the development and use of global health innovations in USAID programs. The report must include information on how USAID is working independently and with partners, donors, and the private sector to develop and bring to scale health products, and how this work is advancing commitments to counter HIV/AIDS, preventable child and maternal deaths, and the spread of infectious diseases.
Sponsor and status
115th Congress (2017–2019)
Enacted — Signed by the President on Jan 3, 2019
This bill was enacted after being signed by the President on January 3, 2019.
19 Cosponsors (11 Democrats, 8 Republicans)
Position statements
What legislators are saying
“Congressman Sires Statement on the Passage of the Global Health Innovation Act of 2017”
—
Rep. Albio Sires [D-NJ8, 2013-2022]
(Sponsor)
on Jan 3, 2019
“The Week Ahead - scheduled votes, committee action and other important notes for the week of January 16, 2018”
—
Rep. David Young [R-IA3, 2015-2018]
on Jan 16, 2018
“THIS WEEK IN CONGRESS - Sablan, Murkowski intro CW bill”
—
Rep. Gregorio Sablan [D-MP]
on Jan 22, 2018
History
|
Dec 18, 2015
|
|
Earlier Version —
Passed House (Senate next)
This activity took place on a related bill, H.R. 2241 (114th). |
|
Mar 21, 2017
|
|
Introduced
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber. |
|
Sep 28, 2017
|
|
Ordered Reported
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.
|
|
Jan 18, 2018
|
|
Passed House (Senate next)
The bill was passed in a vote in the House. It goes to the Senate next. |
|
Mar 20, 2018
|
|
Considered by Senate Committee on Foreign Relations
A committee held a hearing or business meeting about the bill.
|
|
Mar 22, 2018
|
|
Text Published
Updated bill text was published as of Reported by Senate Committee. |
|
Dec 20, 2018
|
|
Passed Senate
The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was by Unanimous Consent so no record of individual votes was made. |
|
Jan 3, 2019
|
|
Enacted — Signed by the President
The President signed the bill and it became law.
|
H.R. 1660 (115th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 1660. This is the one from the 115th Congress.
This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
“H.R. 1660 — 115th Congress: Global Health Innovation Act of 2017.” www.GovTrack.us. 2017. June 9, 2023 <https://www.govtrack.us/congress/bills/115/hr1660>
- show another citation format:
- APA
- Blue Book
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.
